High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura

European Journal of Haematology

Volumn 71, Issue 4, 2003, Pages 283-288

  Ogawara, Hatsue ^a   Handa, Hiroshi ^a   Morita, Kimio ^b   Hayakawa, Masaki ^c   Kojima, Junko ^c   Amagai, Hatsuo ^c   Tsumita, Yuki ^c   Kaneko, Yoriaki ^c   Tsukamoto, Norifumi ^c   Nojima, Yoshihisa ^c   Murakami, Hirokazu ^a  

^a GUNMA UNIVERSITY   (Japan)

^b DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Chronic idiopathic thrombocytopenic purpura; IFN ; IL 4; Intracellular cytokine; Th1 Th2 ratio

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PREDNISOLONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CELL ACTIVATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PRIORITY JOURNAL; SPLENECTOMY; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; AGED; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COHORT STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; IONOMYCIN; IONOPHORES; MALE; MIDDLE AGED; PREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TETRADECANOYLPHORBOL ACETATE; TH1 CELLS; TH2 CELLS; TIME FACTORS;

EID: 0141651537     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00138.x     Document Type: Article

References (28)

1. MOSMANN TR, COFFMAN RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
2. ROMAGNANI S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-257.
3. MOSMANN TR, SAD S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-146.
4. MCMILLAN R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981;304:1135-1147.
5. CINES DB, BLANCHETTE VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008.
6. KELTON JG, CARTER CJ, RODGER C et al. The relationship among platelet associated IgG, platelet lifespan, and reticuloendothelial cell function. Blood 1984;63:1434-1438.
7. PICKER LJ, SINGH MK, ZDRAVESKI Z, TREER JR, WALDROP SL, BERGSTRESSER PR, MAINO VC. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995;86:1408-1419.
8. + T cells. Cytometry 2000;40:60-68.
9. TSUBAKIO T, KURATA Y, YONEZAWA T, KITANI T. Quantification of platelet-associated IgG with competitive solid-phase enzyme immunoassay. Acta Haematol 1981;66: 251-256.
10. SHEARER GM. Th1/Th2 changes in ageing. Mech Ageing Dev 1997;94:1-5.
11. RINK L, CAKMAN I, KIRCHNER H. Altered cytokine production in the elderly. Mech Ageing Dev 1998;102:199-209.
12. SAKATA-KANEKO S, WAKATSUKI Y, MATSUNAGA Y, USUI T, KITA T. Altered Th1/Th2 commitment in human CD4+ T cells with ageing. Clin Exp Immunol 2000;120:267-273.
13. SANDMAND M, BRUUNSGAARD H, KEMP K, ANDERSEN-RANBERG K, PEDERSEN AN, SKINHØJ P, PEDERSEN BK. Is ageing associated with a shift in the balance between type 1 and type 2 cytokines in humans?. Clin Exp Immunol 2002;127:107-114.
14. GARDNER EM, MURASKO DM. Age-related changes in Type 1 and Type 2 cytokine production in humans. Biogerontology 2002;3:271-289.
15. ACKERMAN KD, MARTINO M, HEYMAN R, MOYNA NM, RABIN BS. Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls. Psychosom Med 1998;60:484-491.
16. RAPOPORT MJ, MOR A, VARDI P, RAMOT Y, WINKER R, HINDI A, BISTRITZER T. Decreased secretion of Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokine in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J Autoimmun 1998;11:635-642.
17. H2) T cell clones to activate effector function in macrophages. J Immunol 1989;142:760-765.
18. MONOZ-FERNANDEZ MA, FERNANDEZ MA, FRESNO M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma crusi through a nitric oxide-dependent mechanism. Eur J Immunol 1992;22:301-307.
19. VON DEM BORNE AEGKR, HELMERHORST FM, VAN LEEUWEN EF, PEGELS HG, VON RIESZ E, ENGELFRIET CP. Autoimmune thrombocytopenia: detection of platelet autoantibodies with the suspension immuno- fluorescence test. Br J Haematol 1980;45:319-327.
20. WOODS VL Jr, OH EH, MASON D, MCMILLAN R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984;63:368-375
21. WOODS VL Jr, KURATA Y, MONTGOMERY RR, TANI P, MASON D, OH EH, MCMILLAN R. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. Blood 1984;64:156-160.
22. KOVALOVSKY D, REFEJO D, HOLSBOER F, ARZT E. Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J Neuroimmunol 2000;109:23-29.
23. + T cells in vitro. J Immunol 1996;156:2406-2412.
24. AGARWAL SK, MARSHALL Jr GD. Dexamethasone promotes Type 2 cytokine production primarily through inhibition of Type 1 cytokines. J Interferon Cytokine Res 2001;21:147-155.
25. JUNEJA S, JANUSZEWICZ E, WOLF M, COOPER I. Post-splenectomy lymphocytosis. Clin Lab Haematol 1995;17:335-337.
26. BELLONE G, ASTE-AMEZAGA M, TRICHIERI G, RODECK U. Regulation of NK cell function by TGF-beta 1. J Immunol 1995;155:1066-1073.
27. BRIGHT JJ, SRIRAM S. TGF-β inhibits IL-12 induced activation of Jak-STAT pathway in T lymphocytes. J Immunol 1998;161:1772-1777.
28. KARAKANTZA M, MOUZAKI A, THEODOROPOULOU M, BUSSEL JB, MANIATIS A. Th1 and Th2 cytokines in a patient with Evans' syndrome and profound lymphopenia. Br J Haematol 2000;110:968-970.